Caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceral
Background: Loxoscelism is an important public health problem in Chile and South America, due to the higher rate of cutaneous-visceral involvement. The diagnosis of loxoscelism is mostly clinical without established diagnostic criteria. There is little evidence to support any treatment used in this...
Guardado en:
Autores principales: | , , , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2021
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000500682 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872021000500682 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720210005006822021-11-03Caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceralDroppelmann,KatherineMajluf-Cáceres,PaulaSabatini-Ugarte,NataliaValle,ElizabethHerrera,HernánAcuña,David Brown Recluse Spider Spider Bites Spider Venoms Background: Loxoscelism is an important public health problem in Chile and South America, due to the higher rate of cutaneous-visceral involvement. The diagnosis of loxoscelism is mostly clinical without established diagnostic criteria. There is little evidence to support any treatment used in this condition. Aim: To characterize the clinical features and epidemiology of loxoscelism among patients consulting at the Emergency and Dermatology Services of a clinical hospital between 2013 and 2017. Material and Methods: Review of medical records of patients registered in the electronic clinical record system with a confirmed diagnosis of loxoscelism. Epidemiological, clinical, laboratory tests and treatment variables were analyzed. Results: We reviewed data from 200 patients. Ninety-four percent presented cutaneous loxoscelism and 5.5% cutaneous-visceral loxoscelism. Systemic symptoms were present in 73% of patients with cutaneous-visceral loxoscelism. Patients who developed systemic symptoms had an 18 times higher risk of developing cutaneous-visceral loxoscelism. Laboratory abnormalities were more common in patients with cutaneous-visceral loxoscelism. Not all patients with hematuria had cutaneous-visceral loxoscelism. Most patients required analgesia. Anti-loxosceles serum was not used in any patient. Conclusions: Many questions remain to be answered regarding the diagnosis and treatment of the disease. Studies are required to validate diagnostic criteria for loxoscelism, predictors for visceral involvement and response to treatment.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.149 n.5 20212021-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000500682es10.4067/s0034-98872021000500682 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Brown Recluse Spider Spider Bites Spider Venoms |
spellingShingle |
Brown Recluse Spider Spider Bites Spider Venoms Droppelmann,Katherine Majluf-Cáceres,Paula Sabatini-Ugarte,Natalia Valle,Elizabeth Herrera,Hernán Acuña,David Caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceral |
description |
Background: Loxoscelism is an important public health problem in Chile and South America, due to the higher rate of cutaneous-visceral involvement. The diagnosis of loxoscelism is mostly clinical without established diagnostic criteria. There is little evidence to support any treatment used in this condition. Aim: To characterize the clinical features and epidemiology of loxoscelism among patients consulting at the Emergency and Dermatology Services of a clinical hospital between 2013 and 2017. Material and Methods: Review of medical records of patients registered in the electronic clinical record system with a confirmed diagnosis of loxoscelism. Epidemiological, clinical, laboratory tests and treatment variables were analyzed. Results: We reviewed data from 200 patients. Ninety-four percent presented cutaneous loxoscelism and 5.5% cutaneous-visceral loxoscelism. Systemic symptoms were present in 73% of patients with cutaneous-visceral loxoscelism. Patients who developed systemic symptoms had an 18 times higher risk of developing cutaneous-visceral loxoscelism. Laboratory abnormalities were more common in patients with cutaneous-visceral loxoscelism. Not all patients with hematuria had cutaneous-visceral loxoscelism. Most patients required analgesia. Anti-loxosceles serum was not used in any patient. Conclusions: Many questions remain to be answered regarding the diagnosis and treatment of the disease. Studies are required to validate diagnostic criteria for loxoscelism, predictors for visceral involvement and response to treatment. |
author |
Droppelmann,Katherine Majluf-Cáceres,Paula Sabatini-Ugarte,Natalia Valle,Elizabeth Herrera,Hernán Acuña,David |
author_facet |
Droppelmann,Katherine Majluf-Cáceres,Paula Sabatini-Ugarte,Natalia Valle,Elizabeth Herrera,Hernán Acuña,David |
author_sort |
Droppelmann,Katherine |
title |
Caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceral |
title_short |
Caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceral |
title_full |
Caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceral |
title_fullStr |
Caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceral |
title_full_unstemmed |
Caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceral |
title_sort |
caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceral |
publisher |
Sociedad Médica de Santiago |
publishDate |
2021 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000500682 |
work_keys_str_mv |
AT droppelmannkatherine caracterizacionclinicayepidemiologicade200pacientesconloxoscelismocutaneoycutaneovisceral AT majlufcacerespaula caracterizacionclinicayepidemiologicade200pacientesconloxoscelismocutaneoycutaneovisceral AT sabatiniugartenatalia caracterizacionclinicayepidemiologicade200pacientesconloxoscelismocutaneoycutaneovisceral AT valleelizabeth caracterizacionclinicayepidemiologicade200pacientesconloxoscelismocutaneoycutaneovisceral AT herrerahernan caracterizacionclinicayepidemiologicade200pacientesconloxoscelismocutaneoycutaneovisceral AT acunadavid caracterizacionclinicayepidemiologicade200pacientesconloxoscelismocutaneoycutaneovisceral |
_version_ |
1718437202728321024 |